Kyung Dong Pharmaceutical Co. Ltd (011040) — Capital Reinvestment Ratio
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Capital Reinvestment Ratio of 0.18x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩4.75 Billion) in capital expenditures (₩842.84 Million). Check tangible net worth ratio of Kyung Dong Pharmaceutical Co. Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kyung Dong Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Kyung Dong Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Kyung Dong Pharmaceutical Co. Ltd.
Annual Capital Reinvestment Ratio for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. See Kyung Dong Pharmaceutical Co. Ltd (011040) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | ₩16.93 Billion | ₩20.51 Billion | ▲ +283.3% |
| 2021 | 0.32x | ₩12.42 Billion | ₩3.93 Billion | ▼ -81.1% |
| 2020 | 1.67x | ₩17.12 Billion | ₩28.59 Billion | ▲ +1313.5% |
| 2018 | 0.12x | ₩33.27 Billion | ₩3.93 Billion | ▼ -69.6% |
| 2017 | 0.39x | ₩14.79 Billion | ₩5.74 Billion | ▲ +38.3% |
| 2016 | 0.28x | ₩25.63 Billion | ₩7.19 Billion | ▼ -53.8% |
| 2015 | 0.61x | ₩18.26 Billion | ₩11.10 Billion | ▼ -34.8% |
| 2014 | 0.93x | ₩22.73 Billion | ₩21.17 Billion | ▲ +63.0% |
| 2013 | 0.57x | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩26.08 Billion | ₩2.44 Billion | — |